This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chi, H.
Right arrow Articles by Reynolds, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chi, H.
Right arrow Articles by Reynolds, P. R.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2000, p. 6496-6507, Vol. 20, No. 17
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Targeted Deletion of Minpp1 Provides New Insight into the Activity of Multiple Inositol Polyphosphate Phosphatase In Vivo

Hongbo Chi,1 Xiaonian Yang,2 Paul D. Kingsley,3 Regis J. O'Keefe,4 J. Edward Puzas,4 Randy N. Rosier,4 Stephen B. Shears,2 and Paul R. Reynolds4,*

Department of Pathology and Laboratory Medicine,1 Department of Pediatrics,3 and Department of Orthopaedics,4 University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, and Inositide Signaling Section, Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 277092

Received 18 May 2000/Accepted 23 May 2000

Multiple inositol polyphosphate phosphatase (Minpp1) metabolizes inositol 1,3,4,5,6-pentakisphosphate (InsP5) and inositol hexakisphosphate (InsP6) with high affinity in vitro. However, Minpp1 is compartmentalized in the endoplasmic reticulum (ER) lumen, where access of enzyme to these predominantly cytosolic substrates in vivo has not previously been demonstrated. To gain insight into the physiological activity of Minpp1, Minpp1-deficient mice were generated by homologous recombination. Tissue extracts from Minpp1-deficient mice lacked detectable Minpp1 mRNA expression and Minpp1 enzyme activity. Unexpectedly, Minpp1-deficient mice were viable, fertile, and without obvious defects. Although Minpp1 expression is upregulated during chondrocyte hypertrophy, normal chondrocyte differentiation and bone development were observed in Minpp1-deficient mice. Biochemical analyses demonstrate that InsP5 and InsP6 are in vivo substrates for ER-based Minpp1, as levels of these polyphosphates in Minpp1-deficient embryonic fibroblasts were 30 to 45% higher than in wild-type cells. This increase was reversed by reintroducing exogenous Minpp1 into the ER. Thus, ER-based Minpp1 plays a significant role in the maintenance of steady-state levels of InsP5 and InsP6. These polyphosphates could be reduced below their natural levels by aberrant expression in the cytosol of a truncated Minpp1 lacking its ER-targeting N terminus. This was accompanied by slowed cellular proliferation, indicating that maintenance of cellular InsP5 and InsP6 is essential to normal cell growth. Yet, depletion of cellular inositol polyphosphates during erythropoiesis emerges as an additional physiological activity of Minpp1; loss of this enzyme activity in erythrocytes from Minpp1-deficient mice was accompanied by upregulation of a novel, substitutive inositol polyphosphate phosphatase.


* Corresponding author. Present address: Center for Oral Biology, Aab Institute of Biomedical Sciences, University of Rochester Medical Center, 601 Elmwood Ave., Box 611, Rochester, NY 14642. Phone: (716) 273-1424. Fax: (716) 473-2679. E-mail: Paul_Reynolds{at}urmc.rochester.edu.


Molecular and Cellular Biology, September 2000, p. 6496-6507, Vol. 20, No. 17
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Cho, J., King, J. S., Qian, X., Harwood, A. J., Shears, S. B. (2008). Dephosphorylation of 2,3-bisphosphoglycerate by MIPP expands the regulatory capacity of the Rapoport-Luebering glycolytic shunt. Proc. Natl. Acad. Sci. USA 105: 5998-6003 [Abstract] [Full Text]  
  • Fujii, M., York, J. D. (2005). A Role for Rat Inositol Polyphosphate Kinases rIPK2 and rIPK1 in Inositol Pentakisphosphate and Inositol Hexakisphosphate Production in Rat-1 Cells. J. Biol. Chem. 280: 1156-1164 [Abstract] [Full Text]  
  • Safrany, S. T. (2004). Protocols for Regulation and Study of Diphosphoinositol Polyphosphates. Mol. Pharmacol. 66: 1585-1591 [Abstract] [Full Text]  
  • Orchiston, E. A., Bennett, D., Leslie, N. R., Clarke, R. G., Winward, L., Downes, C. P., Safrany, S. T. (2004). PTEN M-CBR3, a Versatile and Selective Regulator of Inositol 1,3,4,5,6-Pentakisphosphate (Ins(1,3,4,5,6)P5): EVIDENCE FOR Ins(1,3,4,5,6)P5 AS A PROLIFERATIVE SIGNAL. J. Biol. Chem. 279: 1116-1122 [Abstract] [Full Text]  
  • Nantermet, P. V., Xu, J., Yu, Y., Hodor, P., Holder, D., Adamski, S., Gentile, M. A., Kimmel, D. B., Harada, S.-i., Gerhold, D., Freedman, L. P., Ray, W. J. (2004). Identification of Genetic Pathways Activated by the Androgen Receptor during the Induction of Proliferation in the Ventral Prostate Gland. J. Biol. Chem. 279: 1310-1322 [Abstract] [Full Text]  
  • Yu, J., Leibiger, B., Yang, S.-N., Caffery, J. J., Shears, S. B., Leibiger, I. B., Barker, C. J., Berggren, P.-O. (2003). Cytosolic Multiple Inositol Polyphosphate Phosphatase in the Regulation of Cytoplasmic Free Ca2+ Concentration. J. Biol. Chem. 278: 46210-46218 [Abstract] [Full Text]  
  • Ferguson, C. M., Schwarz, E. M., Reynolds, P. R., Puzas, J. E., Rosier, R. N., O'Keefe, R. J. (2000). Smad2 and 3 Mediate Transforming Growth Factor-{beta}1-Induced Inhibition of Chondrocyte Maturation. Endocrinology 141: 4728-4735 [Abstract] [Full Text]